A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Sprue-like enteropathy due to olmesartan
2015
Revista Espanola de Enfermedades Digestivas
The angiotensin II receptor antagonists, such as olmesartan, are prescribed for the treatment of hypertension. In 2013, the FDA collected an alarm of these drugs which was associated with disturbances at duodenal mucosa (1). In 2012 and 2013 two series of patients treated with olmesartan related chronic diarrhea and villous atrophy that did not improve with glutenfree diet were published. In both series diarrhea was improved withdrawing the drug (2,3). More recently, new observations of
doi:10.17235/reed.2015.3791/2015
pmid:26437988
fatcat:v32k6lr33nc6tlc6ftlwo62hfq